Merge LIS software.

Recall Insight

This FDA Devices action (record #Z-0399-2017) was formally reported on November 23, 2016, with the manufacturer initiating the action on March 5, 2015. It is classified under Moderate severity (Class II), with a current status of Terminated. Merge Healthcare, Inc. is listed as the recalling firm, operating out of Hartland, WI. Federal records indicate 413 sites potentially have the affected software units are affected.

The documented reason for this recall is: There is a potential for duplicate container numbers to be created for patients. Distribution data in the federal record shows the product reached: Distribution was made nationwide and to the Virgin Islands. Foreign distribution was made to the Bahamas.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 10 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.